Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Holdings
Biotech
Novo Holdings-backed biotech raises $205M to fill gout care gap
Crystalys and its team of 10 people—and growing—is pushing ahead in hopes of filling the treatment gap for patients with gout.
Gabrielle Masson
Sep 30, 2025 8:00am
Big Pharma-backed GlycoEra raises $130M for protein degraders
May 27, 2025 7:00am
Novo Holdings dials back investment as Trump stumps forecasters
Apr 28, 2025 10:33am
Glycomine's $115M series C to fund genetic disorder ph. 2 plans
Apr 16, 2025 9:20am
Newleos unveils with $93M and 4 ex-Roche programs
Feb 13, 2025 12:00am
Windward generates $200M with Novo Holdings, OrbiMed in tow
Jan 10, 2025 10:02am
